Josh Kaufman's practice focuses on capital markets transactions, primarily in the technology and life sciences verticals. He represents US and foreign private issuers, investment banks and institutional investors in a wide variety of securities transactions, including public offerings and private placements of common and preferred stock, investment grade and high-yield debt and convertible securities, and tender offers and consent solicitations. Josh has advised clients on more than 130 financing transactions with an aggregate value in excess of $100 billion. He also counsels clients with respect to securities law filings and compliance; general corporate and commercial matters; emerging company formation, financing and development; incubator and accelerator buildout and portfolio company investments; mergers and acquisitions; and interactions with security holders, stock exchanges and other regulatory bodies.
Download full bio